Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  GSK Faces $489 Million Fine in China Bribery Case
  CSPC Pharma to Support Drug Discovery Work at Columbia University
  CASI Pharma Pays $11.5 Million for China Rights to Three Spectrum Drugs
  Denovo Biopharma In-licenses Cancer Drug from Lilly
  3SBio Gains China Rights to Pegylated Chemotherapy from JenKem
  BeiGene Books $9 Million Milestone from Merck Serono
  Milestone Scientific Starts Painless Botox Injection JV in China
  BGI Forms Genomic Partnership with the Vancouver Prostate Center
  Institute Curie and Shenzhen Investor Plan $485 Million Cancer Hospital
  Guangzhou Baiyunshan is First-to-China-Market with Generic Viagra
 
Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors